Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-09Substance P Follow-up to a Pilot Study of Aprepitant vs Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2017-05-09Randomized, Double Blinded, Placebo-Controlled Trial of Antibacterial Prophylaxis for the Prevention of Bacterial Infections in the Post-Engraftment Phase After Allogeneic Hematopoeitic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2017-05-08Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
-
CLINICAL_TRIALS study record update · 2017-05-03Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia (CLL)
-
CLINICAL_TRIALS study record update · 2017-04-28A Feasibility And Toxicity Study Of Vaccination With HSP70 For The Treatment Of Chronic Myelogenous Leukemia In Chronic Phase
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-28Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2017-04-26The Molecular Epidemiology of de Novo and Treatment Related 11q23 Leukemia in the Young
-
CLINICAL_TRIALS study record update · 2017-04-25A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies
-
CLINICAL_TRIALS study record update · 2017-04-25CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2017-04-21The Metabolic Syndrome in Pediatric Acute Lymphoblastic Leukemia (ALL).
-
CLINICAL_TRIALS study record update · 2017-04-17Dapsone Induced Methemoglobinemia in Pediatric Hematologic Malignancy and Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2017-04-11Rasburicase to Prevent Graft -Versus-Host Disease
-
CLINICAL_TRIALS study record update · 2017-04-10Renal Dysfunction With Low to Intermediate Dose Methotrexate in Acute Lymphoblastic Leukemia Treatment
-
CLINICAL_TRIALS study record update · 2017-04-05Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
-
CLINICAL_TRIALS study record update · 2017-04-04A Phase I Open-Label, Safety Study of Haploidentical Bone Marrow Transplantation (BMT) After Ex Vivo Treatment of Bone Marrow With Anti-B7.1 and Anti-B7.2 Antibodies
-
CLINICAL_TRIALS study record update · 2017-04-04Delayed Effects of Treatment in Cancer Survivors (DETECS)
-
CLINICAL_TRIALS study record update · 2017-03-29G-CSF and Plerixafor With Sorafenib for Acute Myelogenous Leukemia With FLT3 Mutations
-
CLINICAL_TRIALS study record update · 2017-03-24Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation as Second Transplantation for Patients With Disease Relapse or Myelodysplasia After Prior Autologous Transplantation
-
CLINICAL_TRIALS study record update · 2017-03-22A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
-
CLINICAL_TRIALS study record update · 2017-03-14An Open-Label, Randomized, Multicenter Phase 2 Trial of Dasatinib (SPRYCEL®) vs. Dasatinib Plus Smoothened Antagonist (BMS-833923) in the Treatment of Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia (CML).
-
CLINICAL_TRIALS study record update · 2017-03-10Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Treatment of Adult Patients (>18 Years) With Lymphohematopoietic Disorders
-
CLINICAL_TRIALS study record update · 2017-03-08Feasibility of Implementing Yoga Intervention for Adolescents at St. Jude Children's Research Hospital
-
CLINICAL_TRIALS study record update · 2017-03-06Reduced Intensity Stem Cell Transplant in Children and Young Adults Utilizing Photopheresis, Fludarabine, and Busulfan
-
CLINICAL_TRIALS study record update · 2017-02-27Phase II Study of Pentostatin With Cyclophosphamide and Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2017-02-24Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Cell Transplantation (SCT) for AML With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute Myelogenous Leukemia (AML) in Children: A Children's Oncology Group (COG) Study